NHS and healthcare services tender support

NHS and healthcare procurement

Public evidence The Provider Selection Regime has applied in England since 1 January 2024 when relevant authorities arrange healthcare services within its scope. Updated statutory guidance describes five selection processes and the key criteria. The 2026/27 NHS Standard Contract is mandated for NHS commissioners' clinical-service contracts other than primary care, subject to its stated exceptions and versions. [ 003, 004, 007 ]

Evidence-linked insight · What this changes A credible pursuit identifies the service, commissioner, patient-choice position, provider-selection process and contract form before describing a solution. Goods, staffing, estates, technology and non-healthcare services may instead fall under the Procurement Act, while a mixed requirement needs a documented scope decision. Neither an NHS buyer nor a clinical setting alone determines the route. [ 001, 002, 003, 004 ]

Healthcare selection and public procurement are not interchangeable

Public evidence PSR guidance says relevant authorities include NHS England, integrated care boards, NHS trusts, foundation trusts, local authorities and combined authorities. It also explains direct award processes A, B and C, the most suitable provider process and the competitive process. Direct award does not mean an informal award: the regulations contain decision, conflict, record and transparency requirements. [ 003, 004, 008 ]

Where we would start first Map every component to its CPV and actual purpose, then confirm whether it is healthcare, non-healthcare or an eligible mixed procurement. Record who chose the route and why. A supplier should never describe a preliminary engagement, direct-award intention or framework admission as an open competition, and should not assume that Procurement Act language governs an in-scope PSR service. [ 001, 002, 003, 004, 009 ]

Clinical delivery, transport and innovation frameworks require different evidence

Public evidence The verified examples include a planned eight-lot patient-transport framework, a tender for transport supporting a specialist children's inpatient service, an open health-innovation framework with technology and clinical-service lots, and a dementia-support competition. They involve framework, below-threshold, award and service-contract structures and do not establish one NHS procurement model. [ 009, 010, 011, 012 ]

Evidence-linked insight · What this changes Clinical services need pathway, workforce and outcome evidence; patient transport needs eligibility, mobility, handover and vehicle capacity; digital care needs interoperability, clinical safety and lifecycle support; community support needs referral, accessibility and integration. Use proof from the comparable service and risk. A software implementation or transport contract is not evidence of competence to deliver regulated clinical treatment. [ 005, 006, 009, 010, 011, 012 ]

Commissioners buy pathways, capacity and accountable interfaces

Evidence-linked insight · What this changes ICBs, NHS England and provider organisations may commission or subcontract care, while trusts also buy supporting services, goods and systems. The NHS Standard Contract technical material distinguishes full-length and shorter-form arrangements and requires completed service specifications, prices, quality requirements and reporting schedules. The exact contract and procurement documents govern each pursuit. [ 004, 007, 009, 010, 012 ]

Where we would start first Identify responsible commissioner, contract lead, clinical pathway owner, referrers, receiving providers and patient-choice obligations. Confirm lot and geography, activity assumptions, contract form, mobilisation date, subcontract permissions and information flows. Framework value and eligibility do not guarantee activity, and a commissioner estimate is not a safe workforce or income forecast without referral and capacity assumptions. [ 004, 007, 009, 011 ]

Evaluation tests capability, patient benefit and system fit

Evidence-linked insight · What this changes PSR key criteria cover quality and innovation; value; integration, collaboration and service sustainability; improving access, reducing health inequalities and facilitating choice; and social value. Relevant authorities determine their relative importance and process within the regulations. The dementia-support notice instead uses the Procurement Act, demonstrating why bidders must read the live route rather than apply one scoring template. [ 004, 012 ]

Where we would start first Separate basic selection and regulated eligibility from scored quality and contractual commitments. Trace each answer from patient need through referral, assessment, intervention, escalation, discharge and measurable outcome. Show named clinical and operational ownership, capacity, evidence and cost. Explain limits when a case study concerns another cohort, pathway or commissioning arrangement instead of implying universal transferability. [ 004, 005, 006, 007 ]

Patients need a pathway they can enter, understand and leave safely

Evidence-linked insight · What this changes Healthcare quality is not demonstrated by activity volume alone. The procurement examples expose practical transitions: eligible people require transport to appointments; a specialist inpatient service needs dependable movement; dementia support follows diagnosis; and virtual or diagnostic services must connect technology and clinical delivery. Each transition can create delay, exclusion, duplication or loss of information. [ 009, 010, 011, 012 ]

Evidence-linked insight · What this changes Define eligibility, referral acceptance, reasonable adjustments, consent, waiting-list management, clinical assessment, non-attendance, escalation, transfer and discharge. State what outcome is measured, when, by whom and with which baseline. Avoid guaranteeing recovery or reduced admissions where causality depends on patients, referrers and the wider system; explain contribution and any known data limitation. [ 005, 006, 007, 012 ]

Clinical authority and lived experience have different decision rights

Evidence-linked insight · What this changes Stakeholders can include patients, carers, advocates, commissioners, referrers, clinicians, safeguarding leads, medicines teams, information guardians, provider collaboratives, primary care, ambulance services, local authorities and voluntary organisations. Their concerns vary from safety and access to capacity, choice, continuity, data, workforce and affordability. Consultation does not itself confer clinical or contractual approval. [ 004, 007, 009, 012 ]

Where we would start first Map decisions and hand-offs: who accepts a referral, changes treatment, responds to deterioration, shares information, authorises expenditure and receives complaints. Include accessible patient and carer involvement without disclosing identifiable health information. Obtain specialist approval for clinical claims and avoid implying that NHS England, a trust, patient group or regulator has endorsed the proposed model. [ 005, 006, 007 ]

What usually prevents a safe award

Evidence-linked insight · What this changes Typical barriers are the wrong selection regime, missing CQC registration or incorrect regulated-activity scope, insufficient clinical leadership, an unstaffable rota, weak pathway interfaces, no patient-choice analysis, unsupported digital integration, incomplete data protection, uncosted mobilisation and performance claims without a numerator, denominator or source. These are delivery failures, not merely writing defects. [ 003, 004, 005, 006, 007 ]

Where we would start first Run a barrier review covering entity, exclusions, registrations, licences and professional status, insurance, financial standing, locations, clinical governance, safeguarding, workforce, equipment, medicines, data, subcontractors and premises. Mark each item live, conditional or absent. Do not promise to obtain a mandatory registration after service commencement or present a planned hire as available clinical capacity. [ 001, 002, 005, 006, 010 ]

Regulated scope and accountable leadership must be real

Public evidence CQC says it is an offence to carry on a regulated activity in England without registration and asks applicants to demonstrate safe, effective, caring, responsive and well-led services. Registration is activity, provider and location dependent. It does not prove eligibility for every NHS contract or that a proposed service, site or subcontractor is within the registered scope. [ 005, 006 ]

Where we would start first Before submission, verify the legal entity, regulated activities, conditions, locations, nominated individual and registered manager where relevant. Build a professional-registration and competence matrix for every clinical role. Confirm incident, safeguarding, complaints, medicines, infection, equipment and information-governance ownership. Use current documentary evidence rather than a logo or generic statement of compliance. [ 005, 006, 007 ]

Build the pathway controls before drafting the narrative

Evidence-linked insight · What this changes Useful pre-submission artefacts include a route decision, requirement trace, patient journey, service and capacity model, clinical-governance map, workforce roster, referral and triage rules, escalation matrix, information-flow diagram, interoperability inventory, risk register, quality schedule, mobilisation gates, KPI dictionary and pricing reconciliation. Each must reflect the actual cohort and geography. [ 004, 007, 009, 010, 011, 012 ]

Where we would start first Connect the artefacts. Eligibility rules must drive demand and staffing; clinical risk must drive escalation and competence; information flows must drive consent, access and support; quality measures must drive review and remediation; the service model must reconcile to price. A polished dashboard cannot repair a pathway with unclear responsibility or data whose clinical meaning is unknown. [ 005, 006, 007 ]

Pre-award assurance has limits

Evidence-linked insight · What this changes Bidders may validate sample activity, demonstrate workflow, agree conditional subcontractor support, reserve named leaders, prepare integration designs and progress registration changes where timescales allow. Clarifications should address route, cohort, demand, patient choice, incumbent data, premises, equipment, interfaces, TUPE, payment and acceptance. Procurement rules determine which engagement is permitted. [ 001, 002, 003, 004, 007 ]

Where we would start first No bidder can guarantee future referral volume, complete an unstarted CQC decision, obtain patient consent in advance, force another provider to integrate or validate undisclosed records. Record those dependencies with owner, date and fallback. Do not seek private clinical or commercial assurances outside the stated process, and do not treat a buyer's silence as acceptance of an assumption. [ 003, 004, 006, 007 ]

Clinical governance must follow each decision and exception

Evidence-linked insight · What this changes A service needs defined clinical leadership, scopes of practice, supervision, guidelines, audit, incident response, duty of candour where applicable, safeguarding, complaints and learning. The exact controls vary by regulated activity and pathway. Contract schedules and CQC requirements must be applied to the live service rather than replaced by a generic governance chart. [ 005, 006, 007 ]

Where we would start first Map each assessment, treatment, transport or technology-supported decision to an authorised role and escalation. Define how deterioration, diagnostic uncertainty, failed contact, safeguarding concern, capacity issue and cross-provider disagreement are handled. Show review frequency, evidence and change authority. Never claim a clinical outcome or zero harm; demonstrate how risk is detected, controlled and learned from. [ 005, 006, 009, 010 ]

Capacity depends on productive clinical time and safe cover

Evidence-linked insight · What this changes NHS delivery combines registered professionals, support staff, administrators, drivers, digital specialists and partners according to scope. Headcount does not show available appointments or safe coverage. Induction, supervision, mandatory training, sickness, leave, travel, documentation, multidisciplinary work and escalation all reduce productive time and may create scarce-role constraints. [ 006, 007, 009, 010, 012 ]

Where we would start first Model demand by pathway step, acuity, location and time, then translate it into productive hours, skill mix and cover. Identify credential checks, supervision ratios, on-call arrangements, recruitment lead times and agency or partner limits. Reconcile named people to price and mobilisation. State vacancies and conditional appointments honestly instead of using a recruitment pipeline as proof of day-one capacity. [ 005, 006, 007 ]

Access design must respond to unequal barriers

Evidence-linked insight · What this changes The PSR includes improving access, reducing health inequalities and facilitating choice among its key criteria. Current examples include transport for people unable to travel because of medical condition, culturally appropriate dementia support and services combining digital and clinical options. These examples do not define every inequality or prove that digital access is automatically wider access. [ 004, 009, 011, 012 ]

Where we would start first Use local evidence to identify barriers by geography, disability, language, deprivation, digital access, culture and clinical need. Design referral, communication, venues, transport, remote alternatives and reasonable adjustments accordingly. Define reach and outcome measures with denominators. Avoid claiming that one channel suits everyone or that increased contacts necessarily reduce an inequality. [ 004, 007, 009, 012 ]

Information must remain clinically meaningful across organisations

Evidence-linked insight · What this changes Virtual care, diagnostics, transport and community support all require reliable identifiers, referral data, access control, status and handover. Digital functionality is only one part of the pathway. The WM5G framework combines technology, clinical and management lots, illustrating the need to distinguish product supply from clinical responsibility and service integration. [ 011 ]

Where we would start first Define controller and processor roles, lawful handling, minimum data, identity matching, role access, interoperability, downtime, clinical-safety ownership, retention, audit and exit. Test data quality and workflow with representative users. Never state that an interface is integrated before the receiving system, standard, testing and acceptance are confirmed, or use patient data as public bid evidence. [ 005, 006, 007, 011 ]

Clinical assets need lifecycle and accountability

Evidence-linked insight · What this changes Depending on scope, delivery may rely on vehicles, diagnostic devices, medicines, consumables, remote-monitoring equipment or patient-facing software. Each has ordering, availability, maintenance, calibration, storage, prescribing or authorisation, recall, incident and disposal implications. A manufacturer's specification does not establish fitness for a specific clinical pathway. [ 005, 006, 009, 010, 011 ]

Where we would start first Create an asset and responsibility schedule covering approval, custody, competency, maintenance, spares, contamination control, failure response and evidence. Identify which party makes clinical decisions and which supplies technology or logistics. Price the full lifecycle and handover. Do not substitute products or clinical functionality without the approvals required by the contract and governance system. [ 005, 006, 007 ]

Safeguarding and incident routes must work across hand-offs

Evidence-linked insight · What this changes Patients may disclose abuse, deteriorate during transport, fail to attend, experience a device failure or move between services with incomplete information. A supplier's response must fit the commissioner's safeguarding and patient-safety arrangements while preserving its own statutory and regulatory duties. The precise notification and investigation requirements depend on event and provider role. [ 005, 006, 007, 009, 010 ]

Where we would start first Define recognition, immediate care, escalation, recording, statutory or contractual notification, family communication, investigation, duty of candour where applicable and learning. Exercise hand-offs with partners during mobilisation. Avoid promising that all incidents are preventable; demonstrate rapid control and systemic learning. Keep identifiable or security-sensitive incident detail out of public proof. [ 005, 006, 007 ]

Mobilisation protects continuity while evidence is verified

Evidence-linked insight · What this changes Transition can involve referrals, waiting lists, clinical records, staff, premises, equipment, medicines, vehicles, patient communications, subcontractors and open incidents. Incoming information may be incomplete and cannot be treated as clinically verified merely because it was handed over. Phased assurance must avoid abandoning people already on a pathway. [ 007, 009, 010, 012 ]

Where we would start first Use gates for contract authority, registration, clinical governance, workforce, pathway, information, estates, equipment, safeguarding, reporting and business continuity. Create a patient-safety exception register with owner and interim control. Reconcile volumes and capacity before accepting a cutover. Record buyer acceptance and retain an explicit rollback or continuity plan for a failed dependency. [ 005, 006, 007 ]

Price the pathway, uncertainty and quality system

Evidence-linked insight · What this changes Healthcare prices may be activity based, block, pathway, capitation-like, locally agreed, fixed project or framework call-off depending on the contract. The NHS Standard Contract and payment rules govern applicable clinical arrangements, while transport and technology may use other commercial models. Demand, acuity, non-attendance, travel and scarce workforce can change unit economics. [ 007, 009, 010, 011, 012 ]

Where we would start first Define the priced unit, included pathway steps, volume band, case mix, exclusions, indexation, mobilisation, data, equipment and quality costs. Model referrals, conversion, productive time and capacity. Separate activity risk from outcome and system dependencies. Avoid an unsupported fixed fee that funds neither safe staffing nor demand variation, and do not infer guaranteed call-off from a framework estimate. [ 007, 009, 011 ]

Partnerships must preserve clinical and contractual accountability

Evidence-linked insight · What this changes Delivery can involve NHS providers, independent providers, voluntary organisations, transport companies, laboratories and technology suppliers. The framework examples show multi-lot markets but do not transfer responsibility automatically between parties. A prime remains accountable for the services and flow-down assigned by its contract even where another organisation supplies a critical component. [ 007, 009, 011, 012 ]

Where we would start first Map every entity to patient contact, regulated activity, decision, data, workforce, price and incident role. Verify registrations, competence, insurance and availability. Define referrals, handovers, subcontract consent, audit, step-in and exit. Do not present a partner's NHS experience as the prime's own or assume collaboration will resolve an interface that has no owner. [ 005, 006, 007 ]

Measures need clinical context and action thresholds

Evidence-linked insight · What this changes Possible measures include referral acceptance, waiting time, access by group, completed pathway, clinical outcome, avoidable cancellation, transfer timeliness, safety events, complaints, data quality, workforce stability and continuity. A single average can conceal urgent waits, excluded groups or deterioration. Contract definitions and local baselines determine the valid measure. [ 004, 007, 009, 012 ]

Where we would start first Define numerator, denominator, clock, exclusions, segmentation, data owner, assurance and response for every KPI. Separate referral received, clinically accepted, offered, attended, completed and discharged states. Link thresholds to operational and clinical action. Do not choose a metric only because it produces a favourable number or compare unlike pathways without qualification. [ 007, 012 ]

Wider value must not weaken care

Evidence-linked insight · What this changes PSR includes social value as a key criterion and allows authorities to determine its importance. Healthcare opportunities can support accessible employment, progression, local voluntary capacity, lower-carbon travel and efficient equipment use. Commitments remain procurement specific and must not reduce qualification, staffing, patient choice, infection control or clinical assurance. [ 004, 009, 011, 012 ]

Where we would start first Define each commitment with beneficiary, baseline, quantity, owner, cost, evidence and clinical safeguard. Reduce travel through routing and appropriate remote care, not by denying needed face-to-face assessment. Plan equipment energy, repair and disposal without extending unsafe use. Protect patient confidentiality in social-value reporting and secure finance and operations approval before submission. [ 005, 007, 009, 011 ]

Sector-specific Bid Strengthening Plan

Evidence-linked insight · What this changes Start with eight tests: correct selection regime; registered scope; accountable clinical governance; deliverable capacity; safe patient journey; interoperable information; funded mobilisation; and measurable access and outcomes. Log each gap with source requirement, patient and bid consequence, current evidence, remedy, owner, decision date and residual limitation. [ 003, 004, 005, 006, 007 ]

Where we would start first Resolve illegality, registration, safety and capacity gaps before improving prose. Then reconcile workforce, pathway, partners, information, price and KPIs. Red-team every clinical and outcome claim with a qualified reviewer. Unknown demand, integration or commissioner decisions remain explicit dependencies; they are not permission to create false certainty. [ 004, 005, 006, 007 ]

Bid support, retained capability and proof boundary

Evidence-linked insight · What this changes Bid Champions can coordinate requirement traces, evidence registers, pathway workshops, stakeholder maps, commercial reconciliation, mobilisation gates and review packs. It can help authorised specialists express controls clearly. The client retains clinical design, registration, governance, information, staffing, pricing, partner and bid decisions; Bid Champions is not presented as a healthcare provider, clinician or regulator. [ 003, 004, 005, 006, 007 ]